Evolent Health (EVH) Operating Leases (2019 - 2026)

Evolent Health's Operating Leases history runs 8 years deep, the most recent figure standing at $3.2 million for Q1 2026.

• On a quarterly basis, Operating Leases fell 79.72% year-over-year to $3.2 million in Q1 2026; TTM through Mar 2026 was $3.2 million, a 79.72% decrease from a year earlier, with the FY2025 full-year figure at $3.8 million, down 84.71% from the prior year.
• Operating Leases declined to $3.2 million in Q1 2026 per EVH's latest filing, from $3.8 million in the prior quarter.
• Across five years, Operating Leases topped out at $65.0 million in Q2 2022 and bottomed at $3.2 million in Q1 2026.
• The 5-year median for Operating Leases is $32.5 million (2024), against an average of $35.6 million.
• Across the five-year window, Operating Leases rose 4.16% in 2022 and plunged 84.71% in 2025, its largest moves.
• Year by year, Operating Leases stood at $56.0 million in 2022, then plunged by 32.14% to $38.0 million in 2023, then slumped by 34.31% to $25.0 million in 2024, then plunged by 84.71% to $3.8 million in 2025, then slipped by 17.23% to $3.2 million in 2026.
• Per Business Quant, the three latest EVH Operating Leases figures stand at $3.2 million (Q1 2026), $3.8 million (Q4 2025), and $22.4 million (Q3 2025).